Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ('Ascentage Pharma” or the 'Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, ...

Interpublic Group cited three large account losses from 2024 that impacted the business, especially in media and healthcare.

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Today’s stock market focus is centered on one single sector: technology stocks. The excitement around artificial intelligence ...

Thermo Fisher Scientific posted better-than-expected profit and revenue in its latest quarter.

Amgen saw its price target boosted from $315 to $326 by UBS Group, maintaining a neutral stance. This upgrade reflects a ...